Jericho Security
Series A in 2025
Jericho Security is a cybersecurity company specializing in protecting businesses from generative AI-based threats. It has developed a proprietary generative AI platform, cyberGPT, which simulates realistic cyberattacks, creates new defense strategies, and provides personalized training to enhance cybersecurity efficiency and prevent potential losses.
Together AI
Series B in 2025
Together is a technology services platform that offers a decentralized cloud specifically for artificial intelligence development. The company focuses on constructing open-source generative AI models and infrastructure, providing tools and resources that enable developers and researchers to train, refine, and deploy these models efficiently. Together's platform emphasizes accessibility and user-friendliness, allowing organizations of various sizes to leverage and enhance AI capabilities. By contributing innovative open-source research, models, and datasets, Together plays a significant role in advancing the field of AI and fostering collaborative development efforts.
Fiddler AI
Series B in 2024
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
Enveda Biosciences
Series C in 2024
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.
Physical Intelligence
Series A in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.
Kinetic Automation
Series B in 2024
Kinetic specializes in modernizing automotive infrastructure to accommodate electric and autonomous vehicles. It employs hardware, robotics, software, and AI to deliver swift, accurate, and predictable maintenance services.
LabGenius
Series B in 2024
LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.
Xaira Therapeutics
Venture Round in 2024
Xaira Therapeutics is a biotechnology company that leverages artificial intelligence to revolutionize drug discovery and development. Headquartered in the San Francisco Bay Area, Xaira brings together machine learning experts, expansive data generation, and robust therapeutic product development to advance treatments for various diseases.
Collaborative Robotics
Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.
Together AI
Series A in 2024
Together is a technology services platform that offers a decentralized cloud specifically for artificial intelligence development. The company focuses on constructing open-source generative AI models and infrastructure, providing tools and resources that enable developers and researchers to train, refine, and deploy these models efficiently. Together's platform emphasizes accessibility and user-friendliness, allowing organizations of various sizes to leverage and enhance AI capabilities. By contributing innovative open-source research, models, and datasets, Together plays a significant role in advancing the field of AI and fostering collaborative development efforts.
Physical Intelligence
Seed Round in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.
Sakana AI
Seed Round in 2024
Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.
Inductive Bio
Seed Round in 2023
Inductive Bio develops a machine learning platform that accelerates compound optimization for pharmaceutical research. It focuses on building datasets and ML models to predict absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small molecules, enabling scientists to optimize initial compounds into leads and development candidates more efficiently.
Factory
Seed Round in 2023
Factory is a technology company that develops an AI-based platform for software engineering. Its platform reviews code, addresses bugs, answers questions, and handles routine tasks such as code review, debugging, and refactoring, allowing engineers to delegate tasks and focus on complex problems.
Modal Labs
Series A in 2023
Modal Labs develops machine learning software that enables users to run code in the cloud. Its platform allows for the execution of machine learning models, parallel compute jobs, task queues, web apps, and more. It automates the launch of custom containers and runs scripts faster than on local machines, allowing data science teams to focus on their models without managing infrastructure.
Kinetic Automation
Series A in 2023
Kinetic specializes in modernizing automotive infrastructure to accommodate electric and autonomous vehicles. It employs hardware, robotics, software, and AI to deliver swift, accurate, and predictable maintenance services.
Delphi develops a digital cloning platform that captures an individual's thoughts, experiences, and personality, making their insights available to others in a personalized manner for learning and development.
Jericho Security
Pre Seed Round in 2023
Jericho Security is a cybersecurity company specializing in protecting businesses from generative AI-based threats. It has developed a proprietary generative AI platform, cyberGPT, which simulates realistic cyberattacks, creates new defense strategies, and provides personalized training to enhance cybersecurity efficiency and prevent potential losses.
Together AI
Seed Round in 2023
Together is a technology services platform that offers a decentralized cloud specifically for artificial intelligence development. The company focuses on constructing open-source generative AI models and infrastructure, providing tools and resources that enable developers and researchers to train, refine, and deploy these models efficiently. Together's platform emphasizes accessibility and user-friendliness, allowing organizations of various sizes to leverage and enhance AI capabilities. By contributing innovative open-source research, models, and datasets, Together plays a significant role in advancing the field of AI and fostering collaborative development efforts.
Mythic
Venture Round in 2023
Founded in 2012, Mythic specializes in designing and manufacturing AI-driven silicon chips and inference processors. Its innovative technology brings desktop GPU compute capabilities and neural networks to compact, energy-efficient devices, enabling AI deployment across various industries such as consumer electronics, wearables, and autonomous systems.
Enveda Biosciences
Series B in 2022
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.
Anagenex is a biotechnology company developing a novel platform for drug discovery. This platform focuses on challenging targets by combining machine learning with DNA-encoded libraries and proprietary AI models to accelerate small molecule drug discovery.
LatchBio is a biotechnology company founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman. It focuses on developing a data infrastructure aimed at supporting the open-source biocomputing revolution. The company provides a bioinformatics platform specifically designed for cell and gene therapy startups, offering a modern cloud computing stack that enables biotech labs to manage and execute custom workflows, pipelines, and machine learning models. This platform allows scientists to create bioinformatic queries efficiently, without requiring command-line expertise or the burdens of complex system setups. By streamlining data integration and computational processes, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.
Hugging Face
Series C in 2022
Founded in 2016, Hugging Face is a New York-based company that aims to democratize good machine learning. It provides an open-source platform for collaborating on machine-learning projects, including models, datasets, and applications.
Umba is an African digital bank offering free bank accounts and connected financial services. Founded in 2017, it operates in Kenya and Nigeria, providing customers with complete control of their finances via a single mobile application.
Alife Health
Series A in 2022
Alife Health develops artificial intelligence tools for fertility care to improve pregnancy outcomes. The company provides AI-based health technology that helps doctors select the healthiest embryos and supports IVF planning, aiming to increase the likelihood of healthy pregnancies. It connects fertility specialists with patients to streamline IVF treatment and decision making. Founded in 2020 and headquartered in San Francisco, California, the company focuses on applying deep learning and software to reproductive medicine, enabling clinicians to personalize embryo selection and patient care. Alife Health strives to enhance access to effective fertility treatments and assist prospective parents in achieving successful pregnancies.
Creyon Bio
Series A in 2022
Creyon Bio is a pre-clinical stage company focused on advancing drug development through a data-driven methodology. It specializes in engineering RNA-based medicines and their components by creating proprietary datasets that inform advanced machine learning models. This innovative approach enables the rapid identification of design rules and engineering principles necessary for the development of safe and effective oligonucleotide-based medicines. By leveraging these insights, Creyon Bio aims to improve the efficiency of the drug development process, ultimately contributing to cost savings in the healthcare sector while catering to diverse patient populations.
Gandeeva Therapeutics
Series A in 2022
Gandeeva Therapeutics is a precision biotechnology company that combines cryogenic electron microscopy (cryo-EM) and machine learning to discover and develop therapeutics by targeting and modulating key protein-protein interactions. Its structure-guided drug discovery platform comprises SPOTLIGHT for target prediction and validation, HYPERFOCUS for hit identification from virtual and fragment libraries, and CRYO-CADD for lead optimization. The company pursues a preclinical oncology program focused on difficult-to-treat cancers with novel protein interaction modulators, including interfacial glues and allosteric inhibitors. Headquartered in the Greater Vancouver area of Canada, Gandeeva aims to advance differentiated therapeutics and improve outcomes for patients by leveraging its integrated imaging, modeling, and screening capabilities.
Anagenex
Seed Round in 2022
Anagenex is a biotechnology company developing a novel platform for drug discovery. This platform focuses on challenging targets by combining machine learning with DNA-encoded libraries and proprietary AI models to accelerate small molecule drug discovery.
Founded in 2013, Clarifai specializes in advanced image recognition systems for detecting near-duplicates and enabling visual search. Its platform recognizes various categories, objects, and tags in images, and finds similar images in large uncategorized repositories using a combination of semantic and visual similarity.
MosaicML
Venture Round in 2021
MosaicML is a company focused on creating an efficient infrastructure for training large language models and improving the overall efficiency of neural networks. It develops software and artificial intelligence training algorithms that enhance the training process by utilizing algorithmic techniques such as sparsity and network pruning. These innovations allow users to effectively and securely train large-scale AI models on their proprietary data, while also optimizing for speed, quality, and cost. MosaicML aims to streamline the machine learning model recomposition process, making it easier for organizations to harness the power of AI in their operations.
LatchBio
Seed Round in 2021
LatchBio is a biotechnology company founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman. It focuses on developing a data infrastructure aimed at supporting the open-source biocomputing revolution. The company provides a bioinformatics platform specifically designed for cell and gene therapy startups, offering a modern cloud computing stack that enables biotech labs to manage and execute custom workflows, pipelines, and machine learning models. This platform allows scientists to create bioinformatic queries efficiently, without requiring command-line expertise or the burdens of complex system setups. By streamlining data integration and computational processes, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.
Enveda Biosciences
Series A in 2021
Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.
Primer Technologies
Series C in 2021
Primer Technologies develops software that uses machine learning and natural language processing to parse, collate, and analyze large multilingual document sets. Its platform reads documents, discovers insights, and automatically generates reports comparable to those produced by human analysts. The technology helps governments and corporations monitor and understand a wide range of information across languages, translating vast text data into actionable intelligence. Founded in 2014, Primer Technologies is based in San Francisco. The solution automates the analysis of substantial text datasets, enabling organizations to extract meaning from extensive stores of text data and accelerate investigations and decision-making.
Fiddler AI
Series B in 2021
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
Alife Health
Seed Round in 2021
Alife Health develops artificial intelligence tools for fertility care to improve pregnancy outcomes. The company provides AI-based health technology that helps doctors select the healthiest embryos and supports IVF planning, aiming to increase the likelihood of healthy pregnancies. It connects fertility specialists with patients to streamline IVF treatment and decision making. Founded in 2020 and headquartered in San Francisco, California, the company focuses on applying deep learning and software to reproductive medicine, enabling clinicians to personalize embryo selection and patient care. Alife Health strives to enhance access to effective fertility treatments and assist prospective parents in achieving successful pregnancies.
DeepSpin
Convertible Note in 2021
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.
Hugging Face
Series B in 2021
Founded in 2016, Hugging Face is a New York-based company that aims to democratize good machine learning. It provides an open-source platform for collaborating on machine-learning projects, including models, datasets, and applications.
LabGenius
Series A in 2020
LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.
Recursion Pharmaceuticals
Series D in 2020
Recursion Pharmaceuticals is a clinical-stage biotechnology company that aims to radically improve patients’ lives by decoding biology through the integration of biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company operates a large-scale drug discovery platform built around Recursion OS, an infrastructure layer and a Map of proprietary biological and chemical data, supported by software tools and machine learning to explore biology beyond human bias and identify new therapeutic opportunities. Its platform includes ReChem for selecting and designing compounds, ReScreen and ReScreenRun for planning and automating large-scale experiments, and ReRun, ReAnalyze, and RePredict for digital signatures, data analysis, and predictive modeling of drug relationships. Founded in 2013, the company is based in Salt Lake City, Utah.
Thrive Earlier Detection
Series B in 2020
Thrive Earlier Detection is a healthcare company dedicated to saving lives through early detection of cancer. It develops CancerSEEK, a liquid biopsy test designed to identify various cancers in their earliest stages via blood analysis.
Tecton offers an enterprise-grade feature store, empowering businesses to harness machine learning effectively. Its platform addresses unique ML data requirements, enabling teams to build, serve, and scale features swiftly and reliably.
Rosebud AI
Seed Round in 2020
Rosebud AI develops software that enables users to create digital avatars for various purposes. The platform allows filtering by demographic, age, and style. Based in San Francisco, the company aims to make visual content creation accessible through AI-generated game assets.
Hugging Face
Series A in 2019
Founded in 2016, Hugging Face is a New York-based company that aims to democratize good machine learning. It provides an open-source platform for collaborating on machine-learning projects, including models, datasets, and applications.
Orbital Insight
Series D in 2019
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Fiddler AI
Venture Round in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
LabGenius
Series A in 2019
LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.
Fiddler AI
Series A in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.
Recursion Pharmaceuticals
Series C in 2019
Recursion Pharmaceuticals is a clinical-stage biotechnology company that aims to radically improve patients’ lives by decoding biology through the integration of biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company operates a large-scale drug discovery platform built around Recursion OS, an infrastructure layer and a Map of proprietary biological and chemical data, supported by software tools and machine learning to explore biology beyond human bias and identify new therapeutic opportunities. Its platform includes ReChem for selecting and designing compounds, ReScreen and ReScreenRun for planning and automating large-scale experiments, and ReRun, ReAnalyze, and RePredict for digital signatures, data analysis, and predictive modeling of drug relationships. Founded in 2013, the company is based in Salt Lake City, Utah.
Founded in 2012, Mythic specializes in designing and manufacturing AI-driven silicon chips and inference processors. Its innovative technology brings desktop GPU compute capabilities and neural networks to compact, energy-efficient devices, enabling AI deployment across various industries such as consumer electronics, wearables, and autonomous systems.
Tecton offers an enterprise-grade feature store, empowering businesses to harness machine learning effectively. Its platform addresses unique ML data requirements, enabling teams to build, serve, and scale features swiftly and reliably.
Primer Technologies
Series B in 2018
Primer Technologies develops software that uses machine learning and natural language processing to parse, collate, and analyze large multilingual document sets. Its platform reads documents, discovers insights, and automatically generates reports comparable to those produced by human analysts. The technology helps governments and corporations monitor and understand a wide range of information across languages, translating vast text data into actionable intelligence. Founded in 2014, Primer Technologies is based in San Francisco. The solution automates the analysis of substantial text datasets, enabling organizations to extract meaning from extensive stores of text data and accelerate investigations and decision-making.
Visla Labs
Seed Round in 2018
Visla Labs Inc. is a San Francisco-based company established in 2018 that focuses on developing an artificial intelligence platform tailored for the radiology and healthcare sectors. The company aims to innovate and enhance healthcare delivery through advanced AI technologies, positioning itself as a key player in the evolving landscape of medical diagnostics and patient care. With venture capital support, Visla Labs is poised for significant growth and is working towards achieving critical milestones in its development.
Bright Machines
Series A in 2018
Bright Machines, Inc. is a manufacturing company that specializes in robotic arms and cells for micro factories, focusing on the assembly and inspection of products. Founded in 2018 and headquartered in San Francisco, California, with additional offices in Tel Aviv, China, and Mexico, the company combines robotics and advanced software to enhance manufacturing processes. Its software-defined manufacturing platform utilizes artificial intelligence and machine learning to create adaptable, sensor-rich robots with computer vision capabilities. This innovative approach aims to reduce reliance on manual labor and help businesses meet the increasing demands of modern manufacturing, ultimately improving yields while lowering costs.
Arraiy, Inc. is a technology company based in Palo Alto, California, that specializes in developing a computer vision and machine learning platform tailored for the motion picture and television industry. Founded in 2016 and formerly known as opencv.ai, Arraiy aims to transform the filmmaking process by collaborating with major studios and award-winning artists. The company's platform leverages advanced AI techniques to enhance visual storytelling, allowing creators to seamlessly integrate real and virtual worlds. By focusing on machine learning, Arraiy seeks to expand the creative possibilities for filmmakers, thereby unlocking a new era of visual storytelling. As of 2020, Arraiy operates as a subsidiary of Matterport, Inc.
Founded in 2012, Mythic specializes in designing and manufacturing AI-driven silicon chips and inference processors. Its innovative technology brings desktop GPU compute capabilities and neural networks to compact, energy-efficient devices, enabling AI deployment across various industries such as consumer electronics, wearables, and autonomous systems.
Primer Technologies
Series A in 2017
Primer Technologies develops software that uses machine learning and natural language processing to parse, collate, and analyze large multilingual document sets. Its platform reads documents, discovers insights, and automatically generates reports comparable to those produced by human analysts. The technology helps governments and corporations monitor and understand a wide range of information across languages, translating vast text data into actionable intelligence. Founded in 2014, Primer Technologies is based in San Francisco. The solution automates the analysis of substantial text datasets, enabling organizations to extract meaning from extensive stores of text data and accelerate investigations and decision-making.
Covariant
Seed Round in 2017
Covariant is a developer of artificial intelligence for robotics, focused on creating the Covariant Brain, a universal AI system that empowers robots to perceive, reason, and interact with their environment. The company specializes in AI-based robotics and software, facilitating the deployment of robotics across various operations. Covariant's technology employs advanced techniques such as deep imitation learning, deep reinforcement learning, and meta-learning, allowing users to program robots intuitively. By using a virtual reality headset, clients can guide robots through tasks, simplifying the process of integrating robotics into their workflows.
Primer Technologies
Venture Round in 2017
Primer Technologies develops software that uses machine learning and natural language processing to parse, collate, and analyze large multilingual document sets. Its platform reads documents, discovers insights, and automatically generates reports comparable to those produced by human analysts. The technology helps governments and corporations monitor and understand a wide range of information across languages, translating vast text data into actionable intelligence. Founded in 2014, Primer Technologies is based in San Francisco. The solution automates the analysis of substantial text datasets, enabling organizations to extract meaning from extensive stores of text data and accelerate investigations and decision-making.
Recursion Pharmaceuticals
Series B in 2017
Recursion Pharmaceuticals is a clinical-stage biotechnology company that aims to radically improve patients’ lives by decoding biology through the integration of biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company operates a large-scale drug discovery platform built around Recursion OS, an infrastructure layer and a Map of proprietary biological and chemical data, supported by software tools and machine learning to explore biology beyond human bias and identify new therapeutic opportunities. Its platform includes ReChem for selecting and designing compounds, ReScreen and ReScreenRun for planning and automating large-scale experiments, and ReRun, ReAnalyze, and RePredict for digital signatures, data analysis, and predictive modeling of drug relationships. Founded in 2013, the company is based in Salt Lake City, Utah.
Founded in 2012, Mythic specializes in designing and manufacturing AI-driven silicon chips and inference processors. Its innovative technology brings desktop GPU compute capabilities and neural networks to compact, energy-efficient devices, enabling AI deployment across various industries such as consumer electronics, wearables, and autonomous systems.
Orbital Insight
Series C in 2017
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Pinscreen
Seed Round in 2017
Pinscreen, Inc. is a technology company and visual effects studio based in Santa Monica, California, with a branch in Abu Dhabi, UAE. Founded in 2015 by Professor Hao Li, an expert in computer vision, Pinscreen specializes in advanced generative AI technologies for the film industry and interactive experiences. The company offers comprehensive solutions for AI-driven lip sync, face reenactment, face swaps, de-aging, and avatar digitization. Its innovative technology enables the creation of realistic three-dimensional avatars from selfies, facilitating immersive mixed reality experiences for consumers and scalable content creation tools for professionals. Pinscreen has collaborated with prominent filmmakers and production studios, including Netflix, Amazon Studios, and Warner Bros. Notably, the company achieved several milestones, such as developing the first real-time deepfake technology and demonstrating AI lip sync for a complete feature film. Pinscreen is recognized for its contributions to neural rendering and digital human technology, having received accolades like the Epic MegaGrants in 2020 and participation in the NVIDIA Inception Program.
Arraiy, Inc. is a technology company based in Palo Alto, California, that specializes in developing a computer vision and machine learning platform tailored for the motion picture and television industry. Founded in 2016 and formerly known as opencv.ai, Arraiy aims to transform the filmmaking process by collaborating with major studios and award-winning artists. The company's platform leverages advanced AI techniques to enhance visual storytelling, allowing creators to seamlessly integrate real and virtual worlds. By focusing on machine learning, Arraiy seeks to expand the creative possibilities for filmmakers, thereby unlocking a new era of visual storytelling. As of 2020, Arraiy operates as a subsidiary of Matterport, Inc.
Recursion Pharmaceuticals
Series A in 2016
Recursion Pharmaceuticals is a clinical-stage biotechnology company that aims to radically improve patients’ lives by decoding biology through the integration of biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company operates a large-scale drug discovery platform built around Recursion OS, an infrastructure layer and a Map of proprietary biological and chemical data, supported by software tools and machine learning to explore biology beyond human bias and identify new therapeutic opportunities. Its platform includes ReChem for selecting and designing compounds, ReScreen and ReScreenRun for planning and automating large-scale experiments, and ReRun, ReAnalyze, and RePredict for digital signatures, data analysis, and predictive modeling of drug relationships. Founded in 2013, the company is based in Salt Lake City, Utah.
Founded in 2012, Mythic specializes in designing and manufacturing AI-driven silicon chips and inference processors. Its innovative technology brings desktop GPU compute capabilities and neural networks to compact, energy-efficient devices, enabling AI deployment across various industries such as consumer electronics, wearables, and autonomous systems.
Founded in 2013, Clarifai specializes in advanced image recognition systems for detecting near-duplicates and enabling visual search. Its platform recognizes various categories, objects, and tags in images, and finds similar images in large uncategorized repositories using a combination of semantic and visual similarity.
Recursion Pharmaceuticals
Series A in 2016
Recursion Pharmaceuticals is a clinical-stage biotechnology company that aims to radically improve patients’ lives by decoding biology through the integration of biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company operates a large-scale drug discovery platform built around Recursion OS, an infrastructure layer and a Map of proprietary biological and chemical data, supported by software tools and machine learning to explore biology beyond human bias and identify new therapeutic opportunities. Its platform includes ReChem for selecting and designing compounds, ReScreen and ReScreenRun for planning and automating large-scale experiments, and ReRun, ReAnalyze, and RePredict for digital signatures, data analysis, and predictive modeling of drug relationships. Founded in 2013, the company is based in Salt Lake City, Utah.
Pinscreen
Seed Round in 2016
Pinscreen, Inc. is a technology company and visual effects studio based in Santa Monica, California, with a branch in Abu Dhabi, UAE. Founded in 2015 by Professor Hao Li, an expert in computer vision, Pinscreen specializes in advanced generative AI technologies for the film industry and interactive experiences. The company offers comprehensive solutions for AI-driven lip sync, face reenactment, face swaps, de-aging, and avatar digitization. Its innovative technology enables the creation of realistic three-dimensional avatars from selfies, facilitating immersive mixed reality experiences for consumers and scalable content creation tools for professionals. Pinscreen has collaborated with prominent filmmakers and production studios, including Netflix, Amazon Studios, and Warner Bros. Notably, the company achieved several milestones, such as developing the first real-time deepfake technology and demonstrating AI lip sync for a complete feature film. Pinscreen is recognized for its contributions to neural rendering and digital human technology, having received accolades like the Epic MegaGrants in 2020 and participation in the NVIDIA Inception Program.
Orbital Insight
Series B in 2016
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Nervana is a technology company founded in 2014 and headquartered in San Diego, California. It specializes in machine learning and artificial intelligence, offering a software-as-a-service platform that enables businesses to develop custom deep learning applications. The company's flagship product, Nervana Cloud, provides a comprehensive software solution that utilizes deep learning techniques to facilitate the creation of intelligent applications. Founded by experts in various fields, including machine learning, neuroscience, and chip design, Nervana aims to simplify and scale the use of brain-inspired algorithms in technology development.
Founded in 2013, Clarifai specializes in advanced image recognition systems for detecting near-duplicates and enabling visual search. Its platform recognizes various categories, objects, and tags in images, and finds similar images in large uncategorized repositories using a combination of semantic and visual similarity.
Orbital Insight
Series A in 2015
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Primer Technologies
Seed Round in 2015
Primer Technologies develops software that uses machine learning and natural language processing to parse, collate, and analyze large multilingual document sets. Its platform reads documents, discovers insights, and automatically generates reports comparable to those produced by human analysts. The technology helps governments and corporations monitor and understand a wide range of information across languages, translating vast text data into actionable intelligence. Founded in 2014, Primer Technologies is based in San Francisco. The solution automates the analysis of substantial text datasets, enabling organizations to extract meaning from extensive stores of text data and accelerate investigations and decision-making.
Scaled Inference
Seed Round in 2014
Scaled Inference, Inc. is a Palo Alto, California-based company that specializes in artificial intelligence and machine learning technologies. Founded in 2014, it has developed a cloud-based platform aimed at third parties seeking to enhance their applications and services. This platform offers tools for general-purpose pattern recognition, anomaly detection, and predictive analytics, thereby enabling users to explore innovative applications and advance their computing capabilities. By leveraging its technology, Scaled Inference facilitates the integration of intelligent computing into a variety of software systems and products, including websites, mobile applications, and servers.
Orbital Insight
Seed Round in 2014
Orbital Insight, Inc. is a geospatial analytics company based in Palo Alto, California, established in 2013. The firm develops a cloud-based platform that employs artificial intelligence and machine learning to analyze vast amounts of geospatial data, including satellite imagery, mobile location signals, and other Internet of Things data. This technology enables organizations, including businesses, governments, and NGOs, to gain insights into societal and economic trends that may not be visible to the naked eye. Orbital Insight's products, such as Orbital Insight GO, GO Consumer, and GO Energy, provide users with actionable intelligence regarding infrastructure, supply chain dynamics, and energy resources. By transforming billions of data points into clear, usable information, the company supports data-driven decision-making in various sectors.
Inductive Bio develops a machine learning platform that accelerates compound optimization for pharmaceutical research. It focuses on building datasets and ML models to predict absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small molecules, enabling scientists to optimize initial compounds into leads and development candidates more efficiently.